Thu, July 30, 2020

Frank Morgan Maintained (AMED) at Buy with Increased Target to $260 on, Jul 30th, 2020

Frank Morgan of RBC Capital, Maintained "Amedisys, Inc." (AMED) at Buy with Increased Target from $218 to $260 on, Jul 30th, 2020.

Frank has made no other calls on AMED in the last 4 months.



There is 1 other peer that has a rating on AMED. Out of the 1 peers that are also analyzing AMED, all agrees with Frank's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrew Mok of "UBS" Maintained at Hold with Decreased Target to $190 on, Monday, May 11th, 2020